Promius Pharma launches Sernivo Spray

PRINCETON, N.J. — Dr. Reddy’s Laboratory subsidiary Promius Pharma on Wednesday announced the launch of its Sernivo Spray (betamethasone dipropionate). 

 

The topical steroid is indicated to treat mild to moderate plaque psoriasis in patients older than 18 years of age. 

 

“We are proud to bring Sernivo Spray to patients across the U.S.,” Dr. Reddy’s EVP proprietary products group Raghav Chari said. “This is another significant milestone for Promius Pharma. As an emerging leader in the dermatology space, we are committed to developing innovative treatment options.”